Coppell Advisory Solutions LLC Homology Medicines, Inc. Transaction History

Coppell Advisory Solutions LLC

$502 Billion
Q4 2023

A detailed history of Coppell Advisory Solutions LLC transactions in Homology Medicines, Inc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 11 shares of FIXX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 24 54.17%

Holding current value

Previous $30,000 76.67%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.53 - $1.14 $6 - $14	-13 Reduced 54.17%	11 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.84 - $1.43 $10 - $18	13 Added 118.18%	24 $30,000
Q2 2023 Aug 17, 2023	BUY	$0.83 - $1.12 $9 - $12	11 New	11 $10,000
Q1 2023 May 19, 2023	SELL	$0.91 - $1.69 $21 - $40	-24 Closed	0 $0
Q4 2022 May 19, 2023	BUY	$1.09 - $2.04 $26 - $48	24 New	24 $30,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Account

Coppell Advisory Solutions LLC Homology Medicines, Inc. Transaction History